| From “serum sickness” to “xenosialitis”: Past, present, and future significance of the non-human sialic acid Neu5Gc C Dhar, A Sasmal, A Varki Frontiers in immunology 10, 807, 2019 | 101 | 2019 |
| Human species-specific loss of CMP-N-acetylneuraminic acid hydroxylase enhances atherosclerosis via intrinsic and extrinsic mechanisms K Kawanishi, C Dhar, R Do, N Varki, PLSM Gordts, A Varki Proceedings of the National Academy of Sciences 116 (32), 16036-16045, 2019 | 90 | 2019 |
| Unbiased identification of blood-based biomarkers for pulmonary tuberculosis by modeling and mining molecular interaction networks A Sambarey, A Devaprasad, A Mohan, A Ahmed, S Nayak, ... EBioMedicine 15, 112-126, 2017 | 83 | 2017 |
| Circulating nucleic acids: An analysis of their occurrence in malignancies S Suraj, C Dhar, S Srivastava Biomedical Reports 6 (1), 8-14, 2017 | 41 | 2017 |
| Circulating Mycobacterium tuberculosis DosR latency antigen-specific, polyfunctional, regulatory IL10+ Th17 CD4 T-cells differentiate latent from active tuberculosis S Rakshit, V Adiga, S Nayak, PN Sahoo, PK Sharma, ... Scientific reports 7 (1), 11948, 2017 | 35 | 2017 |
| Circulating HLA-DR+CD4+ effector memory T cells resistant to CCR5 and PD-L1 mediated suppression compromise regulatory T cell function in tuberculosis A Ahmed, V Adiga, S Nayak, JAJ Uday Kumar, C Dhar, PN Sahoo, ... PLoS pathogens 14 (9), e1007289, 2018 | 31 | 2018 |
| Are sialic acids involved in COVID-19 pathogenesis? C Dhar, A Sasmal, S Diaz, A Verhagen, H Yu, W Li, X Chen, A Varki Glycobiology 31 (9), 1068-1071, 2021 | 22 | 2021 |
| Sialoglycan recognition is a common connection linking acidosis, zinc, and HMGB1 in sepsis SS Siddiqui, C Dhar, V Sundaramurthy, A Sasmal, H Yu, ... Proceedings of the National Academy of Sciences 118 (10), e2018090118, 2021 | 15* | 2021 |
| Dietary Neu5Ac intervention protects against atherosclerosis associated with human-like Neu5Gc loss—Brief report K Kawanishi, JK Coker, KV Grunddal, C Dhar, J Hsiao, K Zengler, N Varki, ... Arteriosclerosis, thrombosis, and vascular biology 41 (11), 2730-2739, 2021 | 13 | 2021 |
| HIV skews a balanced Mtb-specific Th17 response in latent tuberculosis subjects to a pro-inflammatory profile independent of viral load S Rakshit, N Hingankar, SV Alampalli, V Adiga, BK Sundararaj, PN Sahoo, ... Cell Reports 33 (9), 2020 | 7 | 2020 |
| High frequency of exon 20 S768I EGFR mutation detected in malignant pleural effusions: A poor prognosticator of NSCLC G D'Souza, C Dhar, V Kyalanoor, L Yadav, M Sharma, M Nawaz S, ... Cancer Reports 3 (5), e1262, 2020 | 7* | 2020 |
| Deep sequencing of near full-length HIV-1 genomes from plasma identifies circulating subtype C and infrequent occurrence of AC recombinant form in Southern India SV Alampalli, MM Thomson, R Sampathkumar, K Sivaraman, AJ UKJ, ... PLoS One 12 (12), e0188603, 2017 | 6 | 2017 |
| N-glycolylated carbohydrates in nature AE Awofiranye, C Dhar, P He, A Varki, MAG Koffas, RJ Linhardt Glycobiology 32 (11), 921-932, 2022 | 3 | 2022 |
| Warning signs from the crypt: Aberrant protein glycosylation marks opportunities for early colorectal cancer detection. D Chandrasekar, C Guerrier, F Alisson-Silva, C Dhar, T Caval, F Schwarz, ... Clinical and Translational Gastroenterology, 10.14309, 2022 | 2 | 2022 |
| Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling C Dhar, P Ramachandran, G Xu, C Pickering, T Čaval, M Wong, R Rice, ... British Journal of Cancer, 1-9, 2024 | 1 | 2024 |
| 43 Harnessing the power of glycoproteomics: a cutting-edge approach for predicting treatment efficacy in metastatic melanoma with immune checkpoint inhibitors YG Najjar, C Pickering, P Aiyetan, G Xu, R Rice, A Mitchell, R Bhadra, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | 1 | 2023 |
| Does SIGLEC8 localize to the subcellular compartment like the Alzheimer's disease protective CD33 splice variant? C Dhar Frontiers in Cellular Neuroscience 17, 1124150, 2023 | 1 | 2023 |
| Testing for latent tuberculosis before starting patients on immune checkpoint inhibitors C Dhar Indian Journal of Cancer 58 (3), 469-470, 2021 | 1 | 2021 |
| Utilizing Publicly Available Cancer Clinicogenomic Data on CBioPortal to Compare Epidermal Growth Factor Receptor Mutant and Wildtype Non-Small Cell Lung Cancer C Dhar Cureus 13 (4), 2021 | 1 | 2021 |
| Reply to Soulillou et al.: Difficulties in extrapolating from animal models exemplify unusual human atherosclerosis susceptibility and mechanisms via CMAH loss K Kawanishi, C Dhar, A Varki, PLSM Gordts Proceedings of the National Academy of Sciences 117 (4), 1847-1848, 2020 | 1 | 2020 |
Ajit VarkiUCSDПідтверджена електронна адреса в ucsd.edu
